Stryker Japan Unveils Pangea Plating System for Fracture Treatment
In October 2023, Stryker Japan, headquartered in Shinjuku, Tokyo, announces the launch of its innovative plating system,
Pangea, designed specifically for the treatment of fractures. This new product line comprises an array of metallic plates and screws, along with a unified platform of surgical instruments designed to ensure precise fixation at fracture sites. Embedded within the
Pangea series are 20 anatomical plates capable of addressing fractures in crucial areas including the humerus, femur, tibia, and fibula, significantly advancing the field of fracture treatment.
This month marks the introduction of three types of plates intended for the humerus, femur, and fibula, with further expansions planned for tibial plates and versatile utility plates in the near future. This strategic rollout aims to enhance Stryker's core trauma line, which interfaces seamlessly with existing intramedullary nails and external fixators. This initiative underscores the company’s commitment to providing comprehensive solutions in fracture care.
The
Pangea series has been meticulously developed by incorporating extensive clinical insights from orthopedic surgeons across various countries, utilizing Stryker’s unique 3D bone database,
SOMA (Stryker Orthopaedics Modeling and Analytics), which includes data from over 35,000 cases involving Japanese patients. The design philosophy of this product line is centered around ensuring the plates conform anatomically to the bone structure, thus optimizing treatment outcomes.
Stryker’s titanium alloy plates are engineered in harmony with cobalt-chromium alloy locking screws that leverage their differential hardness to secure the fracture site effectively. Additionally, the
Variable Angle Locking Technology allows for adjustable screw insertion angles of up to 30 degrees, facilitating optimal positioning during the fixation process.
Moreover, the incorporation of the
Hybrid Locking Compression Hole (Hybrid LC Hole) provides surgeons the flexibility to choose between locking screws or compression techniques during surgeries, tailored to the specific fracture patterns encountered. This attribute significantly improves operational efficiency and enhances the surgeon's ability to navigate complex situations during procedures.
The cohesive integration of these plates with common screws and instruments streamlines surgical workflows, fostering a more efficient operating environment.
With the launch of Pangea, Stryker Japan not only enhances its portfolio of fracture treatment products but also elevates its ability to meet the evolving needs of the healthcare sector, ultimately contributing to improved patient outcomes. By addressing the clinical demands more effectively than ever before, Stryker reaffirms its mission of advancing medical technology.
About Stryker Japan
Stryker Japan operates as a subsidiary of Stryker Corporation, headquartered in Michigan, USA. Stryker is recognized as a global leader in the medical technology field, dedicated to improving healthcare alongside healthcare professionals. The company delivers innovative medical devices and services across various domains including surgical equipment, neurotechnology, and orthopedics, impacting over 150 million patients worldwide each year. For more information about Stryker Japan and its offerings, visit
www.stryker.com/jp.
Manufacturer: Stryker Japan, Inc.